{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:34:31Z","timestamp":1767825271896,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":617,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Ramathibodi Foundation"},{"name":"National Research University"},{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.bbmt.2013.04.023","type":"journal-article","created":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T08:13:51Z","timestamp":1367568831000},"page":"1259-1262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Pretransplant Immunosuppression followed by Reduced-Toxicity Conditioning and Stem Cell Transplantation in High-Risk Thalassemia: A Safe Approach to Disease Control"],"prefix":"10.1016","volume":"19","author":[{"given":"Usanarat","family":"Anurathapan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samart","family":"Pakakasama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piya","family":"Rujkijyanont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nongnuch","family":"Sirachainan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duantida","family":"Songdej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ampaiwan","family":"Chuansumrit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somtawin","family":"Sirireung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pimlak","family":"Charoenkwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arunee","family":"Jetsrisuparb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surapol","family":"Issaragrisil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artit","family":"Ungkanont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosarin","family":"Sruamsiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supanart","family":"Srisala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borje S.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suradej","family":"Hongeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2013.04.023_bib1","series-title":"Marrow transplantation in thalassemia","author":"Lucarelli","year":"2004"},{"key":"10.1016\/j.bbmt.2013.04.023_bib2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bbmt.2007.05.004","article-title":"A\u00a0new stratification strategy that identifies a subset of class III patients with an adverse prognosis among children with beta thalassemia major undergoing a matched related allogeneic stem cell transplantation","volume":"13","author":"Mathews","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.04.023_bib3","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood-2010-09-306829","article-title":"HLA-matched sibling bone marrow transplantation for thalassemia major","volume":"117","author":"Sabloff","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.04.023_bib4","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood-2003-08-2800","article-title":"New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years","volume":"104","author":"Sodani","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.04.023_bib5","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ajh.21002","article-title":"Reduced-intensity stem cell transplantation for treatment of class 3 Lucarelli severe thalassemia patients","volume":"82","author":"Hongeng","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2013.04.023_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2012-04-423822","article-title":"Allogeneic hematopoietic stem cell transplantation in thalassemia major: Results of reduced-toxicity conditioning regimen based on the use of treosulfan","volume":"120","author":"Bernado","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.04.023_bib7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.bbmt.2012.11.007","article-title":"Treosulfan-thiotepa-fludarabine\u2013based conditioning regimen for allogeneic transplantation in patients with thalassemia major: A single-center experience from north India","volume":"19","author":"Choudhary","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.04.023_bib8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/bbmt.2002.v8.pm12374451","article-title":"Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: Study of pharmacokinetics and early clinical outcomes","volume":"8","author":"Russell","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.04.023_bib9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1182\/blood-2004-02-0414","article-title":"Once-daily intravenous busulfan and fludarabine: Clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS","volume":"104","author":"de Lima","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.04.023_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2007.01.025","article-title":"A\u00a0CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses","volume":"322","author":"Venken","year":"2007","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.bbmt.2013.04.023_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.blre.2007.10.001","article-title":"Advances in the allogeneic transplantation for thalassemia","volume":"22","author":"Lucarelli","year":"2008","journal-title":"Blood Rev"},{"key":"10.1016\/j.bbmt.2013.04.023_bib12","doi-asserted-by":"crossref","first-page":"a011825","DOI":"10.1101\/cshperspect.a011825","article-title":"Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia","volume":"2","author":"Lucarelli","year":"2012","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"10.1016\/j.bbmt.2013.04.023_bib13","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2217\/imt.12.95","article-title":"Hematopoietic stem cell transplantation for thalassemia","volume":"4","author":"Elborai","year":"2012","journal-title":"Immunotherapy"},{"key":"10.1016\/j.bbmt.2013.04.023_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1054\/blre.2002.0192","article-title":"The cure of thalassemia by bone marrow transplantation","volume":"16","author":"Lucarelli","year":"2002","journal-title":"Blood Rev"},{"key":"10.1016\/j.bbmt.2013.04.023_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.24493","article-title":"Risk-adopted allogeneic hematopoietic stem cell transplantation using a reduced-intensity regimen for children with thalassemia major","author":"Hussein","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2013.04.023_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1399-3046.2008.00953.x","article-title":"Impact of pretransplant splenectomy on patients with beta-thalassemia major undergoing a matched related allogeneic stem cell transplantation","volume":"13","author":"Mathews","year":"2009","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2013.04.023_bib17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/em.20603","article-title":"Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies","volume":"51","author":"Valdez","year":"2010","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/j.bbmt.2013.04.023_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.bmt.1703775","article-title":"Fludarabine in combination with cyclophosphamide decreases incidence of GVHD and maintains effective graft-versus-leukemia effect after allogeneic stem cell transplantation in murine lymphocytic leukemia","volume":"31","author":"Weiss","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.04.023_bib19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.bbmt.2008.06.009","article-title":"Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: A matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide","volume":"14","author":"Bredeson","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.04.023_bib20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1053\/bbmt.2002.v8.pm12234171","article-title":"Correction of phenotype on a thalassemia mouse model using nonmyeloablative marrow transplantation regimen","volume":"8","author":"Bradly","year":"2002","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113001912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113001912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:46:13Z","timestamp":1761057973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879113001912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1083879113001912"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.04.023","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pretransplant Immunosuppression followed by Reduced-Toxicity Conditioning and Stem Cell Transplantation in High-Risk Thalassemia: A Safe Approach to Disease Control","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}